Exact Sciences says the $190 million acquisition of Marshfield-based PreventionGenetics will expand its cancer diagnostics capabilities.
The move also sets up the Madison company’s entrance into the field of hereditary cancer testing, which focuses on detecting heritable genetic mutations that could increase the risk of developing certain cancers.
"With our deep relationships in primary ...
